FindTrial
Sign In

Cytoreductive Surgery (CRS)

PROCEDURE2 trials

Sponsors

Mercy Medical Center, Professor Fernando Figueira Integral Medicine Institute

Conditions

Epithelial Ovarian CancerFallopian Tube CancerFallopian Tube CarcinomaOvarian CancerOvarian CarcinomaPrimary Peritoneal CarcinomaStage III Ovarian CancerStage IV Ovarian Cancer

Phase 2

HOT: HIPEC in Ovarian Cancer as Initial Treatment
Active, not recruitingNCT02124421
Mercy Medical CenterEpithelial Ovarian Cancer, Fallopian Tube Cancer, Fallopian Tube Carcinoma +4
Start: 2014-04-30End: 2028-04-30Updated: 2024-11-19
Short-course HIPEC in Advanced Epithelial Ovarian Cancer
CompletedNCT02249013
Professor Fernando Figueira Integral Medicine InstituteOvarian Cancer
Start: 2015-02-28End: 2021-02-23Updated: 2021-03-18

Related Papers

Quality of life in a phase 2 trial of short-course hyperthermic intraperitoneal chemotherapy (HIPEC) at interval debulking surgery for high tumor burden ovarian cancer
Revista do Colégio Brasileiro de Cirurgiões2020-01-018 citations
388 Short-course HIPEC at the time of interval debulking surgery for high tumor burden ovarian cancer: preliminary results of a pioneering clinical trial in brazil
2019-09-01
Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach.
2017-12-139 citations
Exploring flow rate selection in HIPEC procedures
Revista do Colégio Brasileiro de Cirurgiões2016-12-017 citations
A phase II randomized study: Outcomes after cytoreductive surgery (CRS) with or without carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) followed by adjuvant chemotherapy as initial treatment of advanced stage (stage III/IV) ovarian, fallopian tube, and primary peritoneal cancer.
Journal of Clinical Oncology2016-05-202 citations